日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer

阿特珠单抗联合FOLFOX方案治疗III期错配修复缺陷型结肠癌

Sinicrope, Frank A; Ou, Fang-Shu; Arnold, Dirk; Peters, Walter R; Behrens, Robert J; Lieu, Christopher H; Matin, Khalid; Cohen, Deirdre J; Potter, Samara L; Nixon, Andrew B; Kottschade, Lisa A; Kathol, Emily; Frankel, Wendy L; Shergill, Ardaman; Hsu, Dennis; Reinacher-Schick, Anke; Mehan, Paul; Gold, Philip J; Khalil, Maged F; Zemla, Tyler; Gatten, Clare; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Ensuring the Future of Cooperative Group Cancer Clinical Trials: A Call for Comprehensive Support and Prioritization

确保合作组癌症临床试验的未来:呼吁全面支持和优先考虑

Lieu, Christopher H; Sanoff, Hanna K

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model

XPO1抑制剂联合伊立替康在临床前结直肠癌模型中的疗效

Lentz, Robert W; Dominguez, Adrian T A; Balmaceda, Nicole Baranda; Arcaroli, John J; Bagby, Stacey M; Binns, Cameron A; Smoots, Stephen G; Jackson, Marilyn M; Macbeth, Morgan; Holmstoen, Tessa; Banerjee, Tapahsama; Whitty, Phaedra A; Yi, S Stephen; Lieu, Christopher H; Messersmith, Wells A; Pitts, Todd M

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group

将循环肿瘤DNA检测纳入临床试验:美国国家癌症研究所胃肠肿瘤循环肿瘤DNA工作组的立场文件

Rajdev, Lakshmi; King, Gentry G; Lieu, Christopher H; Cohen, Stacey A; Pant, Shubham; Uboha, Nataliya V; Deming, Dustin; Malla, Midhun; Kasi, Anup; Klute, Kelsey; Spencer, Kristen R; Dasari, Arvind; Morris, Van K; Botta, Gregory; Lowy, Andrew M; O'Hara, Mark H; Eads, Jennifer; King, Daniel; Shah, Manish A; Hong, Theodore S; Parikh, Aparna; Klempner, Samuel J; Jabbour, Salma K; Chawla, Akhil; Molena, Daniela; George, Thomas J; Gibson, Michael K; Allegra, Carmen; Goodman, Karyn; Eng, Cathy; Philip, Philip A

Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer

风险与回报并无二致:不同的化疗方案并不能改善II期早期结肠癌的预后

Leary, Jacob B; Hu, Junxiao; Leal, Alexis; Davis, S Lindsey; Kim, Sunnie; Lentz, Robert; Friedrich, Tyler; Herter, Whitney; Messersmith, Wells A; Lieu, Christopher H

Oligometastatic pancreatic cancer: current state of management and emerging therapies

寡转移性胰腺癌:目前的治疗现状和新兴疗法

Khomiak, Andrii; Balmaceda, Nicole B; Ghaffar, Sumaya A; Lieu, Christopher H; Del Chiaro, Marco; Messersmith, Wells A; Lentz, Robert W

A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors

一项针对晚期实体瘤患者的Tankyrase抑制剂Basroparib的首次人体剂量递增I期研究

Lieu, Christopher H; Lenz, Heinz-Josef; Benson, Al B; Meng, Xue; Kim, Uk-Il; Kim, Song Hyun; Kim, Kyungjin; Sung, Moo Je

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

新型CD47阻断联合疗法治疗难治性微卫星稳定型转移性结直肠癌的II期临床试验和临床前评估

Lentz, Robert W; Lang, Julie; Pitts, Todd M; Blatchford, Patrick; Hu, Junxiao; Jordan, Kimberly R; Van Bokhoven, Adrie; Bagby, Stacey M; Dominguez, Adrian T A; Binns, Cameron A; Robinson, Hannah R; Balmaceda, Nicole; Baiyee, Emily; Leal, Alexis D; Kim, Sunnie S; Davis, S Lindsey; Lieu, Christopher H; Wadlow, Raymond C; Spencer, Kristen; Scott, Aaron J; Boland, Patrick M; Hochster, Howard S; Messersmith, Wells A

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

科罗拉多大学癌症中心肿瘤学I期临床试验中纳入了更多不同类型的患者群体

Alsafar, Ahmed; Kareem, Sama L; Corr, Bradley R; Lieu, Christopher H; Wilky, Breelyn; Davis, S Lindsey; Camidge, D Ross; Jimeno, Antonio; Messersmith, Wells A; Nicklawsky, Andrew; Pacheco, Daniel; Borrayo, Evelinn A; McDermott, Jessica D; Diamond, Jennifer R

Beyond mindfulness: the importance of body compassion in colorectal cancer distress

超越正念:身体关怀在结直肠癌痛苦中的重要性

Zimmaro, Lauren A; Christie, Aimee J; Nicklawsky, Andrew; Altman, Jennifer K; Carson, James W; Lieu, Christopher H; Fang, Carolyn Y; Reese, Jennifer B